AusCann Group Holdings Ltd |
High - |
Low - |
Trades - |
Turnover $0 |
Volume 0 |
| 13 November 2026 at 6:58am | ||||
|
Market Cap (13-Nov) $18,062,432 (1,390th) |
Close (30-Jun) $0.040 |
Volume (30-Jun) 0 |
Shortsold (21-Feb) 50,867 (0.01%) (619th) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -0.06 |
CPAT-01 Improves Pain, Lameness and Quality of Life in Dogs
AC8 released this announcement to the ASX on 30 April 2021, 8:46. The announcement is marked as price sensitive, and is 4 page(s) in length and 313.48kb in size.
You can view all announcements from AC8 and see how they appear on a price chart on the announcements page.
At the date of this announcement, AC8 was 0.006% short sold according to ASIC data. It was ranked the 612th most shorted stock on the ASX. It remains ranked 619th as of the latest reported data (21 February 2022).
| Other Recent Announcements from AC8 | |
|---|---|
| Final Director's Interest Notice - C. Mews | 29 June 2023, 9:44 |
| Initial Director's Interest Notice - B. Mitchell | 29 June 2023, 9:44 |
| Appointment of Independent Non-Executive Director | 29 June 2023, 9:19 |
| CPAT-01 Improves Pain, Lameness and Quality of Life in Dogs | 30 April 2021, 8:46 |
| March 2021 Quarterly Activities and Cashflow Reports | 30 April 2021, 8:03 |
| AusCann Receives R&D Tax Incentive Refund of $1.6m | 23 April 2021, 8:33 |
| Chief Executive Officer Terms of Appointment | 23 April 2021, 8:23 |
If you were already registered, log in here.